Skip to main content
. 2019 Dec 16;2019(12):CD004290. doi: 10.1002/14651858.CD004290.pub3

12.2. Analysis.

12.2

Comparison 12 Target of rapamycin inhibitors (TOR‐I) versus calcineurin inhibitors (CNI): subgroup analyses, Outcome 2 All acute rejection (risk of bias for sequence generation and allocation concealment).